GlucoTrack Inc (GCTK) - Total Assets
Based on the latest financial reports, GlucoTrack Inc (GCTK) holds total assets worth $7.84 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore debt repayment capacity of GlucoTrack Inc to assess how comfortably operating cash covers total debt obligations.
GlucoTrack Inc - Total Assets Trend (2011–2025)
This chart illustrates how GlucoTrack Inc's total assets have evolved over time, based on quarterly financial data. See GCTK book value for net asset value and shareholders' equity analysis.
GlucoTrack Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
GlucoTrack Inc's total assets of $7.84 Million consist of 97.8% current assets and 2.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 94.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how GlucoTrack Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see GCTK stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: GlucoTrack Inc's current assets represent 97.8% of total assets in 2025, an increase from 91.2% in 2011.
- Cash Position: Cash and equivalents constituted 94.2% of total assets in 2025, up from 86.9% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
GlucoTrack Inc Competitors by Total Assets
Key competitors of GlucoTrack Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.12 Billion |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Ocumetics Technology Corp
V:OTC
|
Canada | CA$1.15 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
|
Osteopore Ltd
AU:OSX
|
Australia | AU$2.77 Million |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
GlucoTrack Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.61 | 4.52 | 7.44 |
| Quick Ratio | 1.61 | 4.52 | 7.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.89 Million | $4.49 Million | $8.03 Million |
GlucoTrack Inc - Advanced Valuation Insights
This section examines the relationship between GlucoTrack Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.04 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | 32.1% |
| Total Assets | $7.84 Million |
| Market Capitalization | $1.37 Million USD |
Valuation Analysis
Below Book Valuation: The market values GlucoTrack Inc's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: GlucoTrack Inc's assets grew by 32.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for GlucoTrack Inc (2011–2025)
The table below shows the annual total assets of GlucoTrack Inc from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $7.84 Million | +32.13% |
| 2024-12-31 | $5.93 Million | +20.94% |
| 2023-12-31 | $4.91 Million | +101.19% |
| 2022-12-31 | $2.44 Million | -61.09% |
| 2021-12-31 | $6.26 Million | -40.93% |
| 2020-12-31 | $10.61 Million | +867.70% |
| 2019-12-31 | $1.10 Million | +59.26% |
| 2018-12-31 | $688.19K | -58.76% |
| 2017-12-31 | $1.67 Million | -32.18% |
| 2016-12-31 | $2.46 Million | +15.39% |
| 2015-12-31 | $2.13 Million | -66.41% |
| 2014-12-31 | $6.35 Million | +130.33% |
| 2013-12-31 | $2.76 Million | +238.36% |
| 2012-12-31 | $814.57K | -62.68% |
| 2011-12-31 | $2.18 Million | -- |
About GlucoTrack Inc
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications… Read more